NCT05907954 (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05187884 Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma Status COMPLETED Phase PHASE2